Skin Cutaneous Melanoma: Correlation between copy number variations of arm-level result and selected clinical features
(WT cohort)
Maintained by TCGA GDAC Team (Broad Institute/MD Anderson Cancer Center/Harvard Medical School)
Overview
Introduction

This pipeline computes the correlation between significant arm-level copy number variations (cnvs) and selected clinical features.

Summary

Testing the association between copy number variation 40 arm-level results and 7 clinical features across 23 patients, no significant finding detected with Q value < 0.25.

  • No arm-level cnvs related to clinical features.

Results
Overview of the results

Table 1.  Get Full Table Overview of the association between significant copy number variation of 40 arm-level results and 7 clinical features. Shown in the table are P values (Q values). Thresholded by Q value < 0.25, no significant finding detected.

Clinical
Features
Time
to
Death
AGE PRIMARY
SITE
OF
DISEASE
GENDER LYMPH
NODE
METASTASIS
TUMOR
STAGECODE
NEOPLASM
DISEASESTAGE
nCNV (%) nWild-Type logrank test t-test Fisher's exact test Fisher's exact test Chi-square test t-test Chi-square test
1p gain 4 (17%) 19 0.32
(1.00)
0.0779
(1.00)
0.178
(1.00)
0.59
(1.00)
0.0559
(1.00)
0.194
(1.00)
1q gain 8 (35%) 15 0.0635
(1.00)
0.275
(1.00)
0.0424
(1.00)
0.667
(1.00)
0.194
(1.00)
0.27
(1.00)
3p gain 3 (13%) 20 0.89
(1.00)
0.682
(1.00)
0.0107
(1.00)
1
(1.00)
0.543
(1.00)
0.144
(1.00)
3q gain 4 (17%) 19 0.588
(1.00)
0.732
(1.00)
0.00903
(1.00)
0.59
(1.00)
0.0559
(1.00)
0.0314
(1.00)
4p gain 7 (30%) 16 0.993
(1.00)
0.268
(1.00)
0.376
(1.00)
1
(1.00)
0.394
(1.00)
0.209
(1.00)
4q gain 3 (13%) 20 0.911
(1.00)
0.113
(1.00)
0.486
(1.00)
1
(1.00)
6p gain 8 (35%) 15 0.269
(1.00)
0.705
(1.00)
0.0424
(1.00)
0.667
(1.00)
0.508
(1.00)
0.288
(1.00)
7p gain 7 (30%) 16 0.951
(1.00)
0.959
(1.00)
1
(1.00)
1
(1.00)
0.0615
(1.00)
0.525
(1.00)
7q gain 6 (26%) 17 0.636
(1.00)
0.444
(1.00)
0.822
(1.00)
0.64
(1.00)
0.353
(1.00)
0.295
(1.00)
8p gain 6 (26%) 17 0.204
(1.00)
0.625
(1.00)
0.195
(1.00)
0.64
(1.00)
0.11
(1.00)
0.0364
(1.00)
8q gain 9 (39%) 14 0.989
(1.00)
0.349
(1.00)
0.502
(1.00)
1
(1.00)
0.0929
(1.00)
0.0103
(1.00)
12p gain 4 (17%) 19 0.935
(1.00)
0.326
(1.00)
0.0443
(1.00)
0.59
(1.00)
0.543
(1.00)
0.544
(1.00)
12q gain 3 (13%) 20 0.981
(1.00)
0.696
(1.00)
0.332
(1.00)
0.59
(1.00)
15q gain 3 (13%) 20 0.907
(1.00)
0.255
(1.00)
1
(1.00)
0.59
(1.00)
17q gain 3 (13%) 20 0.643
(1.00)
0.912
(1.00)
0.0457
(1.00)
0.217
(1.00)
0.822
(1.00)
0.21
(1.00)
18p gain 6 (26%) 17 0.365
(1.00)
0.00125
(0.282)
0.141
(1.00)
0.155
(1.00)
0.394
(1.00)
0.0805
(1.00)
18q gain 4 (17%) 19 0.946
(1.00)
0.00787
(1.00)
0.178
(1.00)
0.0932
(1.00)
0.607
(1.00)
0.0314
(1.00)
20p gain 9 (39%) 14 0.543
(1.00)
0.828
(1.00)
0.355
(1.00)
1
(1.00)
0.517
(1.00)
0.407
(1.00)
20q gain 10 (43%) 13 0.459
(1.00)
0.551
(1.00)
0.0826
(1.00)
0.68
(1.00)
0.796
(1.00)
0.558
(1.00)
21q gain 3 (13%) 20 0.289
(1.00)
0.923
(1.00)
0.692
(1.00)
1
(1.00)
22q gain 6 (26%) 17 0.894
(1.00)
0.886
(1.00)
0.141
(1.00)
0.155
(1.00)
0.14
(1.00)
0.0877
(1.00)
1p loss 3 (13%) 20 0.0653
(1.00)
0.948
(1.00)
1
(1.00)
1
(1.00)
2p loss 3 (13%) 20 0.946
(1.00)
0.303
(1.00)
0.692
(1.00)
1
(1.00)
2q loss 4 (17%) 19 0.552
(1.00)
0.132
(1.00)
0.291
(1.00)
1
(1.00)
0.543
(1.00)
0.544
(1.00)
4p loss 3 (13%) 20 0.582
(1.00)
0.121
(1.00)
1
(1.00)
0.59
(1.00)
0.822
(1.00)
0.761
(1.00)
6q loss 6 (26%) 17 0.00227
(0.512)
0.0158
(1.00)
1
(1.00)
0.64
(1.00)
0.829
(1.00)
0.881
(1.00)
9p loss 9 (39%) 14 0.844
(1.00)
0.669
(1.00)
1
(1.00)
1
(1.00)
0.186
(1.00)
0.638
(1.00)
9q loss 6 (26%) 17 0.715
(1.00)
0.973
(1.00)
0.822
(1.00)
0.64
(1.00)
0.0615
(1.00)
0.525
(1.00)
10p loss 11 (48%) 12 0.326
(1.00)
0.243
(1.00)
0.714
(1.00)
0.414
(1.00)
0.578
(1.00)
0.625
(1.00)
10q loss 9 (39%) 14 0.312
(1.00)
0.21
(1.00)
0.355
(1.00)
1
(1.00)
0.843
(1.00)
0.868
(1.00)
11p loss 6 (26%) 17 0.757
(1.00)
0.43
(1.00)
0.511
(1.00)
0.371
(1.00)
0.727
(1.00)
0.822
(1.00)
11q loss 8 (35%) 15 0.651
(1.00)
0.129
(1.00)
0.694
(1.00)
1
(1.00)
0.729
(1.00)
0.766
(1.00)
12q loss 3 (13%) 20 0.56
(1.00)
0.0115
(1.00)
1
(1.00)
1
(1.00)
0.672
(1.00)
0.21
(1.00)
13q loss 4 (17%) 19 0.867
(1.00)
0.0161
(1.00)
1
(1.00)
0.59
(1.00)
0.3
(1.00)
0.934
(1.00)
14q loss 5 (22%) 18 0.658
(1.00)
0.104
(1.00)
0.194
(1.00)
1
(1.00)
0.727
(1.00)
0.544
(1.00)
16q loss 4 (17%) 19 0.0525
(1.00)
0.142
(1.00)
0.753
(1.00)
1
(1.00)
0.3
(1.00)
0.761
(1.00)
17p loss 3 (13%) 20 0.487
(1.00)
0.983
(1.00)
0.692
(1.00)
0.59
(1.00)
0.672
(1.00)
0.252
(1.00)
17q loss 3 (13%) 20 0.402
(1.00)
0.246
(1.00)
0.692
(1.00)
0.0932
(1.00)
18q loss 3 (13%) 20 0.298
(1.00)
0.698
(1.00)
0.486
(1.00)
0.59
(1.00)
0.149
(1.00)
0.252
(1.00)
21q loss 3 (13%) 20 0.0328
(1.00)
0.74
(1.00)
0.486
(1.00)
1
(1.00)
0.615
(1.00)
0.352
(1.00)
Methods & Data
Input
  • Mutation data file = broad_values_by_arm.mutsig.cluster.txt

  • Clinical data file = SKCM-WT.clin.merged.picked.txt

  • Number of patients = 23

  • Number of significantly arm-level cnvs = 40

  • Number of selected clinical features = 7

  • Exclude genes that fewer than K tumors have mutations, K = 3

Survival analysis

For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R

Student's t-test analysis

For continuous numerical clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the clinical values between tumors with and without gene mutations using 't.test' function in R

Fisher's exact test

For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R

Chi-square test

For multi-class clinical features (nominal or ordinal), Chi-square tests (Greenwood and Nikulin 1996) were used to estimate the P values using the 'chisq.test' function in R

Q value calculation

For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.

Download Results

This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.

References
[1] Bland and Altman, Statistics notes: The logrank test, BMJ 328(7447):1073 (2004)
[2] Lehmann and Romano, Testing Statistical Hypotheses (3E ed.), New York: Springer. ISBN 0387988645 (2005)
[3] Fisher, R.A., On the interpretation of chi-square from contingency tables, and the calculation of P, Journal of the Royal Statistical Society 85(1):87-94 (1922)
[4] Greenwood and Nikulin, A guide to chi-squared testing, Wiley, New York. ISBN 047155779X (1996)
[5] Benjamini and Hochberg, Controlling the false discovery rate: a practical and powerful approach to multiple testing, Journal of the Royal Statistical Society Series B 59:289-300 (1995)